Sharon M Moe Selected Research

Cinacalcet (Sensipar)

11/2019	Angiotensin-related genetic determinants of cardiovascular disease in patients undergoing hemodialysis.
1/2019	Fibroblast Growth Factor 23 Genotype and Cardiovascular Disease in Patients Undergoing Hemodialysis.
10/2017	Effect of Etelcalcetide vs Cinacalcet on Serum Parathyroid Hormone in Patients Receiving Hemodialysis With Secondary Hyperparathyroidism: A Randomized Clinical Trial.
3/2016	Lessons Learned from EVOLVE for Planning of Future Randomized Trials in Patients on Dialysis.
1/2016	Cinacalcet, dialysate calcium concentration, and cardiovascular events in the EVOLVE trial.
7/2015	Cinacalcet, Fibroblast Growth Factor-23, and Cardiovascular Disease in Hemodialysis: The Evaluation of Cinacalcet HCl Therapy to Lower Cardiovascular Events (EVOLVE) Trial.
6/2015	Effects of Cinacalcet on Fracture Events in Patients Receiving Hemodialysis: The EVOLVE Trial.
5/2015	The Effects of Cinacalcet in Older and Younger Patients on Hemodialysis: The Evaluation of Cinacalcet HCl Therapy to Lower Cardiovascular Events (EVOLVE) Trial.
11/2014	Effects of cinacalcet on atherosclerotic and nonatherosclerotic cardiovascular events in patients receiving hemodialysis: the EValuation Of Cinacalcet HCl Therapy to Lower CardioVascular Events (EVOLVE) trial.
12/2013	The clinical course of treated hyperparathyroidism among patients receiving hemodialysis and the effect of cinacalcet: the EVOLVE trial.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sharon M Moe Research Topics

Disease

51	Chronic Renal Insufficiency 06/2022 - 01/2004
28	Vascular Calcification 01/2022 - 02/2002
26	Secondary Hyperparathyroidism 06/2022 - 01/2003
23	Chronic Kidney Disease-Mineral and Bone Disorder (Renal Rickets) 03/2022 - 05/2004
19	Kidney Diseases (Kidney Disease) 01/2020 - 06/2005
15	Cardiovascular Diseases (Cardiovascular Disease) 01/2021 - 04/2004
11	Chronic Kidney Failure (Chronic Renal Failure) 03/2022 - 02/2002
8	Hyperphosphatemia 01/2021 - 11/2002
7	Heart Failure 07/2021 - 09/2007
4	Hyperparathyroidism 01/2022 - 08/2009
4	Inflammation (Inflammations) 01/2021 - 01/2005
3	Calciphylaxis 01/2022 - 06/2014
3	Cysts 07/2021 - 07/2009
3	Renal Insufficiency (Renal Failure) 01/2021 - 01/2010
3	Cardiac Sudden Death (Sudden Cardiac Arrest) 01/2021 - 07/2015
3	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 01/2020 - 12/2007
3	Disease Progression 01/2019 - 07/2009
3	Osteoporosis 01/2017 - 11/2012
3	Myocardial Infarction 01/2016 - 09/2007
3	Unstable Angina 01/2016 - 09/2007
3	Hypercalcemia (Milk Alkali Syndrome) 12/2015 - 04/2004
2	Hypotension (Low Blood Pressure) 06/2022 - 01/2019
2	Hypertension (High Blood Pressure) 01/2022 - 06/2008
2	Pain (Aches) 01/2022 - 01/2020
2	Peripheral Vascular Diseases (Peripheral Vascular Disease) 01/2021 - 09/2007
2	Hypocalcemia 02/2020 - 12/2012
2	Pruritus (Itching) 01/2020 - 02/2013
2	Bone Diseases (Bone Disease) 01/2017 - 11/2003
2	Sudden Death 01/2016 - 11/2014
2	Hepatitis C 01/2010 - 06/2008
2	Heart Diseases (Heart Disease) 10/2009 - 06/2006
1	Wounds and Injuries (Trauma) 01/2022
1	Azotemia 01/2022
1	Gastrointestinal Diseases (Functional Gastrointestinal Disorders) 10/2021
1	Hypoglycemia (Reactive Hypoglycemia) 07/2021
1	Autosomal Dominant Polycystic Kidney (ADPKD) 07/2021
1	Edema (Dropsy) 07/2021
1	Primary hyperoxaluria type 1 01/2021

Drug/Important Bio-Agent (IBA)

37	MineralsIBA 03/2022 - 10/2002
32	CalciumIBA 01/2020 - 10/2002
29	Parathyroid Hormone (Parathormone)IBA 03/2022 - 01/2003
27	Phosphorus (Red Phosphorus)IBA 01/2022 - 10/2002
17	Cinacalcet (Sensipar)FDA Link 11/2019 - 01/2003
14	Phosphates (Orthophosphate)IBA 01/2020 - 11/2002
13	Proteins (Proteins, Gene)FDA Link 01/2020 - 02/2002
13	Vitamin D FDA LinkGeneric 07/2015 - 11/2003
8	Collagen Type I (Type I Collagen)IBA 01/2021 - 02/2002
8	Alkaline PhosphataseIBA 11/2006 - 02/2002
7	Fibroblast Growth Factor-23IBA 01/2022 - 02/2011
7	OsteopontinIBA 11/2006 - 02/2002
7	Integrin-Binding SialoproteinIBA 11/2006 - 02/2002
6	etelcalcetide hydrochlorideIBA 03/2022 - 10/2017
4	Diphosphonates (Bisphosphonates)IBA 06/2022 - 01/2013
4	Advanced Glycation End ProductsIBA 01/2021 - 01/2003
4	Biomarkers (Surrogate Marker)IBA 03/2016 - 12/2007
4	Calcitriol (Calcijex)FDA LinkGeneric 01/2016 - 07/2005
4	alpha-2-HS-GlycoproteinIBA 12/2015 - 01/2005
3	Zoledronic Acid (Zometa)FDA Link 06/2022 - 04/2014
3	Hormones (Hormone)IBA 01/2021 - 07/2017
3	Dietary PhosphorusIBA 01/2018 - 11/2003
3	Transcription Factors (Transcription Factor)IBA 01/2015 - 09/2004
3	SterolsIBA 12/2013 - 11/2003
3	N- (2- chlorophenylpropyl)- 1- (3- methoxyphenyl)ethylamineIBA 09/2011 - 07/2009
3	Calcifediol (Calcidiol)FDA Link 06/2009 - 06/2005
2	SodiumIBA 01/2022 - 11/2021
2	PotassiumIBA 11/2021 - 10/2017
2	EnzymesIBA 07/2021 - 06/2008
2	Pharmaceutical PreparationsIBA 01/2020 - 06/2015
2	DNA (Deoxyribonucleic Acid)IBA 11/2019 - 01/2019
2	CreatinineIBA 01/2019 - 01/2010
2	NitrogenIBA 01/2019 - 10/2017
2	Urea (Carbamide)FDA LinkGeneric 01/2019 - 10/2017
2	MicroRNAs (MicroRNA)IBA 01/2015 - 01/2013
2	Phosphotransferases (Kinase)IBA 01/2015 - 09/2010
2	Calcium-Sensing ReceptorsIBA 09/2011 - 07/2009
2	hydroxide ionIBA 07/2011 - 06/2009
2	Dietary ProteinsIBA 02/2011 - 01/2009
2	Biological ProductsIBA 12/2007 - 07/2006
2	Uremic ToxinsIBA 01/2004 - 03/2003
1	Vasopressins (Vasopressin)IBA 06/2022
1	NADPH Oxidases (NAD(P)H oxidase)IBA 03/2022
1	setanaxibIBA 03/2022
1	Reactive Oxygen Species (Oxygen Radicals)IBA 03/2022
1	Metoprolol (Toprol-XL)FDA LinkGeneric 01/2022
1	Antihypertensive Agents (Antihypertensives)IBA 01/2022
1	Analgesics (Analgesic Drugs)IBA 01/2022
1	Losartan (Cozaar)FDA LinkGeneric 01/2022
1	Saccharated Ferric Oxide (Venofer)FDA Link 01/2022
1	Carvedilol (Coreg)FDA LinkGeneric 01/2022
1	SNF472IBA 01/2022
1	ferric citrateIBA 01/2022
1	IronIBA 01/2022
1	NucleotidesIBA 01/2022
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 07/2021
1	Pioglitazone (Actos)FDA Link 07/2021
1	ThiazolidinedionesIBA 07/2021

Therapy/Procedure

23	Renal Dialysis (Hemodialysis) 01/2021 - 01/2003
22	Therapeutics 06/2022 - 01/2003
2	Surgical Amputation (Amputations) 01/2021 - 09/2007
1	Polypharmacy 01/2022